Management of Patients with Diabetic Macular Edema Switched from Dexamethasone Intravitreal Implant to Fluocinolone Acetonide Intravitreal Implant.
dexamethasone implant
diabetic macular edema
fluocinolone acetonide implant
intravitreal therapy
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
05 Nov 2022
05 Nov 2022
Historique:
received:
12
09
2022
revised:
13
10
2022
accepted:
20
10
2022
entrez:
11
11
2022
pubmed:
12
11
2022
medline:
12
11
2022
Statut:
epublish
Résumé
To assess anatomical and functional outcomes after switching from dexamethasone implant (DEXi) to fluocinolone acetonide implant (FAci) in 113 diabetic macular edema eyes, a multicentric retrospective observational study was conducted. Seventy-five eyes (73.5%) were switched 1−8 weeks after their last DEXi. The mean best-corrected visual acuity improved to 59.8 letters at month 4 and remained stable during the follow-up. The mean central macular thickness (CMT) significantly decreased during the follow-up, with a minimum of 320.9 μm at month 3. The baseline CMT was higher in eyes that received the last DEXi >8 weeks versus <8 weeks before the first FAci (p < 0.021). After FAci injection, additional treatments were needed in 37 (32.7%) eyes. A longer diabetes duration (p = 0.009), a longer time between the last DEXi and the first FAci (p = 0.035), and a high baseline CMT (p = 0.003) were risk factors for additional treatments. The mean intraocular pressure was <19 mmHg at all timepoints, with no difference between eyes receiving the last DEXi ≤8 weeks or >8 weeks before the switch. Switching from DEXi to FAci in DME is effective and safe. A short time between the last DEXi and the first FAci reduced CMT fluctuations and the need for early additional treatments.
Identifiants
pubmed: 36365209
pii: pharmaceutics14112391
doi: 10.3390/pharmaceutics14112391
pmc: PMC9693281
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Ophthalmol Retina. 2018 Jun;2(6):567-573
pubmed: 31047610
Eye (Lond). 2021 Dec;35(12):3459
pubmed: 33649577
Expert Opin Biol Ther. 2016;16(3):365-74
pubmed: 26674182
FASEB J. 2004 Sep;18(12):1450-2
pubmed: 15231732
Eye (Lond). 2017 Dec;31(12):1707-1715
pubmed: 28737758
Br J Ophthalmol. 2016 Jun;100(6):796-801
pubmed: 26581718
Pharmaceutics. 2021 Jan 07;13(1):
pubmed: 33430389
Ophthalmology. 2014 Oct;121(10):1904-14
pubmed: 24907062
Ophthalmology. 2012 Oct;119(10):2125-32
pubmed: 22727177
Acta Diabetol. 2020 Apr;57(4):469-478
pubmed: 31749051
Ophthalmology. 2010 Jul;117(7):1393-9.e3
pubmed: 20202684
Br J Ophthalmol. 2019 Aug;103(8):1072-1077
pubmed: 30242062
Br J Ophthalmol. 2021 Mar;105(3):414-419
pubmed: 32461262
J Pharmacol Sci. 2018 Dec;138(4):219-232
pubmed: 30503676
Surv Ophthalmol. 1984 May;28 Suppl:452-61
pubmed: 6379946
Invest Ophthalmol Vis Sci. 2011 Jan 05;52(1):80-6
pubmed: 20702826
Eye (Lond). 2022 May;36(5):1012-1018
pubmed: 33972705
BMJ Open Ophthalmol. 2019 Mar 29;4(1):e000271
pubmed: 31179398
Ophthalmologica. 2010;224 Suppl 1:25-30
pubmed: 20714178
Int Med Case Rep J. 2019 Apr 11;12:93-102
pubmed: 31114396
Curr Med Res Opin. 2020 Jun;36(6):959-965
pubmed: 32267790
Eur J Ophthalmol. 2022 Jul;32(4):1890-1899
pubmed: 35139688
Eye Vis (Lond). 2015 Sep 30;2:17
pubmed: 26605370
J Ocul Pharmacol Ther. 2015 Feb;31(1):11-6
pubmed: 25562126
JAMA Ophthalmol. 2018 Mar 1;136(3):257-269
pubmed: 29392288
Eur J Ophthalmol. 2019 Nov;29(6):573-584
pubmed: 31238719
Diabetes Care. 2017 Mar;40(3):412-418
pubmed: 28223445
Proc Natl Acad Sci U S A. 1999 Sep 14;96(19):10836-41
pubmed: 10485912
Eur J Ophthalmol. 2021 Nov;31(6):3196-3202
pubmed: 33426902
Invest Ophthalmol Vis Sci. 2018 Jan 1;59(1):1-12
pubmed: 29297055
Int Med Case Rep J. 2019 May 31;12:161-169
pubmed: 31213929
Retina. 2015 Dec;35(12):2440-9
pubmed: 26352555
Diabetes Care. 2012 Mar;35(3):556-64
pubmed: 22301125
Ophthalmol Ther. 2019 Mar;8(1):51-62
pubmed: 30560505
Ophthalmic Surg Lasers Imaging Retina. 2016 May 1;47(5):426-35
pubmed: 27183546
Eye (Lond). 2020 Mar;34(3):480-490
pubmed: 31320738
Ophthalmol Retina. 2018 Dec;2(12):1179-1187
pubmed: 31047187
Ther Adv Ophthalmol. 2020 May 22;12:2515841420917768
pubmed: 32548568
Retina. 2017 Apr;37(4):753-760
pubmed: 27471826
Ophthalmic Res. 2020;63(2):114-121
pubmed: 31801148
Retina. 2010 Jul-Aug;30(7):1090-4
pubmed: 20616686
Eur J Ophthalmol. 2020 Mar;30(2):382-391
pubmed: 30884972
Ophthalmic Surg Lasers Imaging Retina. 2020 May 1;51(5):298-306
pubmed: 32511735
Curr Med Res Opin. 2017 Oct;33(sup2):3-4
pubmed: 28930489
Cell Biosci. 2014 May 14;4:27
pubmed: 24955234
Ophthalmology. 2013 Mar;120(3):583-587
pubmed: 23218184
BMJ Open Ophthalmol. 2020 Apr 08;5(1):e000416
pubmed: 32518834
Ophthalmology. 2013 Sep;120(9):1843-51
pubmed: 23706947
Ophthalmology. 1995 Jan;102(1):7-16
pubmed: 7831044
Biomed Res Int. 2018 Aug 28;2018:8289253
pubmed: 30246026
Ophthalmology. 2011 Apr;118(4):626-635.e2
pubmed: 21459216
Clin Ophthalmol. 2013;7:503-9
pubmed: 23503099